Talk:Melanotan II

Discussion page·2 threads·no archives

This is the discussion page for the article Melanotan II. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Melanoma case reportsResolved

The confounding here is severe — self-selection for tanning behaviour and increased surveillance both inflate the apparent association. The article must say so without dismissing the mechanistic concern. — MelanocortinMil (talk) 09:50, 16 January 2026 (UTC)

Three-part formulation: mechanism exists, reports exist, causation not demonstrated. That is as far as the evidence goes. ✓ Done — HedgeHedda (talk) 13:25, 16 January 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Non-selectivity as the themeDone

Framing the whole article around non-selectivity explains both the effects sought and the effects not sought, which is more useful than listing them separately. — ReceptorRhoda (talk) 10:20, 20 April 2026 (UTC)

And it makes the later selective compounds legible as a correction rather than as unrelated drugs. ✓ Done — MelanocortinMil (talk) 13:55, 20 April 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

This page was last edited on 20 April 2026, by MelanocortinMil. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).